Literature DB >> 22328002

Symptoms resolution post-cholecystectomy: patient selection is very important.

Vui Heng Chong.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22328002     DOI： 10.1007/s11605-012-1834-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  7 in total

Review 1.  American gastroenterological association technical review on the evaluation of dyspepsia.

Authors:  Nicholas J Talley; Nimish B Vakil; Paul Moayyedi
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

2.  Factors associated with gastrointestinal symptom overlap and clustering in a predominant Malay Asian population.

Authors:  Vui Heng Chong; Raja Isteri Pengiran
Journal:  J Gastrointestin Liver Dis       Date:  2008-12       Impact factor: 2.008

3.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

4.  Overlap of gastrointestinal symptom complexes in a US community.

Authors:  G R Locke; A R Zinsmeister; S L Fett; L J Melton; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2005-02       Impact factor: 3.598

5.  Relationship between persistence of abdominal symptoms and successful outcome after cholecystectomy.

Authors:  C R Weinert; D Arnett; D Jacobs; R L Kane
Journal:  Arch Intern Med       Date:  2000-04-10

6.  Risk assessment in cholelithiasis: is cholecystectomy always to be preferred?

Authors:  Marlies C Mertens; Jan A Roukema; Vincent P W Scholtes; Jolanda De Vries
Journal:  J Gastrointest Surg       Date:  2010-05-26       Impact factor: 3.452

7.  Abdominal symptoms: do they disappear after cholecystectomy?

Authors:  M Y Berger; T C Olde Hartman; A M Bohnen
Journal:  Surg Endosc       Date:  2003-06-17       Impact factor: 4.584
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.